How to Research AmpyraT as a Treatment for Multiple Sclerosis

The food and Drug Administration (FDA) recently approved AmpyraT (formerly known as fampridine SR, from Acorda Therapeutics) as a symptomatic treatment to improve walking for people with Multiple Sclerosis (MS). There are many reputable websites where there is information to research AmpyraT as a treatment for MS.

For the full article click here.